Egypt Explores Pharma, Healthcare Investment With US Firm

(MENAFN- Daily News Egypt) Egypt's Ministry of Health has discussed investment opportunities in healthcare and pharmaceutical manufacturing with USbased Pure Peptides Pharmaceutical, as part of the government's drive to attract foreign investment and localise drug production.

Health Minister Khaled Abdel Ghaffar met with company founder Lawrence Messick to explore potential areas of cooperation in the Egyptian market. Abdel Ghaffar stressed Egypt's commitment to providing a supportive investment environment for healthcare projects, highlighting the country's broader strategy to strengthen pharmaceutical security and expand specialised healthcare services.

Ministry spokesperson Hossam Abdel Ghaffar said the talks covered opportunities in pharmaceutical manufacturing, elderly care, and clinical nutrition, in line with Egypt's plans to diversify and enhance specialised healthcare offerings. He added that the government is keen to facilitate project implementation, encourage technology transfer, and introduce international expertise into the local market.

As part of the discussions, Abdel Ghaffar invited a company delegation to visit Egypt's pharmaceutical city Gypto Pharma and the Egyptian Drug Authority to review manufacturing and regulatory capabilities and explore potential strategic partnerships.

Egypt aims to consolidate its position as a regional hub for pharmaceutical manufacturing by attracting foreign investment and expanding domestic production capacity. The meeting, attended by senior ministry officials and company representatives via video conference, reflects Cairo's ongoing efforts to integrate global expertise into its healthcare and pharmaceutical sectors.

MENAFN16052026000153011029ID1111125182